Equitec Proprietary Markets’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$5K 289
2022
Q3
$5K Buy
+100
New +$4.13K ﹤0.01% 202

Other funds holding CCXI

Equitec Proprietary Markets's CCXI Position: Q4 2022 in Review

Equitec Proprietary Markets sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 100 shares — an estimated $5K sold.

Equitec Proprietary Markets first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $5K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Equitec Proprietary Markets reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Equitec Proprietary Markets sold 100 ChemoCentryx, Inc. shares in Q4 2022, an estimated $5K.
  • Equitec Proprietary Markets first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Equitec Proprietary Markets's ChemoCentryx, Inc. position peaked at $5K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Equitec Proprietary Markets's 13F filing for Q4 2022, filed 31 Jan 2023.